298 related articles for article (PubMed ID: 18449417)
1. Successful in vivo propagation of factor IX-producing hepatocytes in mice: potential for cell-based therapy in haemophilia B.
Tatsumi K; Ohashi K; Kataoka M; Tateno C; Shibata M; Naka H; Shima M; Hisanaga M; Kanehiro H; Okano T; Yoshizato K; Nakajima Y; Yoshioka A
Thromb Haemost; 2008 May; 99(5):883-91. PubMed ID: 18449417
[TBL] [Abstract][Full Text] [Related]
2. Propagating factor IX-producing hepatocytes for haemophilia B therapy.
Ofosu FA
Thromb Haemost; 2008 May; 99(5):799-800. PubMed ID: 18449406
[No Abstract] [Full Text] [Related]
3. Human hepatocyte propagation system in the mouse livers: functional maintenance of the production of coagulation and anticoagulation factors.
Tatsumi K; Ohashi K; Tateno C; Yoshizato K; Yoshioka A; Shima M; Okano T
Cell Transplant; 2012; 21(2-3):437-45. PubMed ID: 22793051
[TBL] [Abstract][Full Text] [Related]
4. Genetic modification of donor hepatocytes improves therapeutic efficacy for hemophilia B in mice.
Wu YM; Kao CY; Huang YJ; Yu IS; Lee HS; Lai HS; Lee PH; Lin CN; Lin SW
Cell Transplant; 2010; 19(9):1169-80. PubMed ID: 20412633
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of hepatocyte transplantation on hemophilia B.
Tatsumi K; Ohashi K; Shima M; Nakajima Y; Okano T; Yoshioka A
Transplantation; 2008 Jul; 86(1):167-70. PubMed ID: 18622295
[TBL] [Abstract][Full Text] [Related]
6. Near completely humanized liver in mice shows human-type metabolic responses to drugs.
Tateno C; Yoshizane Y; Saito N; Kataoka M; Utoh R; Yamasaki C; Tachibana A; Soeno Y; Asahina K; Hino H; Asahara T; Yokoi T; Furukawa T; Yoshizato K
Am J Pathol; 2004 Sep; 165(3):901-12. PubMed ID: 15331414
[TBL] [Abstract][Full Text] [Related]
7. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus.
Dandri M; Burda MR; Török E; Pollok JM; Iwanska A; Sommer G; Rogiers X; Rogler CE; Gupta S; Will H; Greten H; Petersen J
Hepatology; 2001 Apr; 33(4):981-8. PubMed ID: 11283864
[TBL] [Abstract][Full Text] [Related]
8. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.
Meuleman P; Libbrecht L; De Vos R; de Hemptinne B; Gevaert K; Vandekerckhove J; Roskams T; Leroux-Roels G
Hepatology; 2005 Apr; 41(4):847-56. PubMed ID: 15791625
[TBL] [Abstract][Full Text] [Related]
9. Liver tissue engineering utilizing hepatocytes propagated in mouse livers in vivo.
Ohashi K; Tatsumi K; Tateno C; Kataoka M; Utoh R; Yoshizato K; Okano T
Cell Transplant; 2012; 21(2-3):429-36. PubMed ID: 22793050
[TBL] [Abstract][Full Text] [Related]
10. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.
Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G
J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528
[TBL] [Abstract][Full Text] [Related]
11. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection.
Meuleman P; Steyaert S; Libbrecht L; Couvent S; Van Houtte F; Clinckspoor F; de Hemptinne B; Roskams T; Vanlandschoot P; Leroux-Roels G
Clin Chim Acta; 2006 Apr; 366(1-2):156-62. PubMed ID: 16253217
[TBL] [Abstract][Full Text] [Related]
12. Human hepatocytes can repopulate mouse liver: histopathology of the liver in human hepatocyte-transplanted chimeric mice and toxicologic responses to acetaminophen.
Sato Y; Yamada H; Iwasaki K; Tateno C; Yokoi T; Yoshizato K; Horii I
Toxicol Pathol; 2008 Jun; 36(4):581-91. PubMed ID: 18467679
[TBL] [Abstract][Full Text] [Related]
13. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of basic fibroblast growth factor-pretreated adipose tissue-derived stromal cells enhances regression of liver fibrosis in mice.
Kamada Y; Yoshida Y; Saji Y; Fukushima J; Tamura S; Kiso S; Hayashi N
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G157-67. PubMed ID: 19056764
[TBL] [Abstract][Full Text] [Related]
15. Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.
Jiang L; Li JG; Lan L; Wang YM; Mao Q; You JP
Transplant Proc; 2010 Nov; 42(9):3773-8. PubMed ID: 21094855
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice.
Suemizu H; Hasegawa M; Kawai K; Taniguchi K; Monnai M; Wakui M; Suematsu M; Ito M; Peltz G; Nakamura M
Biochem Biophys Res Commun; 2008 Dec; 377(1):248-52. PubMed ID: 18840406
[TBL] [Abstract][Full Text] [Related]
17. GH enhances proliferation of human hepatocytes grafted into immunodeficient mice with damaged liver.
Masumoto N; Tateno C; Tachibana A; Utoh R; Morikawa Y; Shimada T; Momisako H; Itamoto T; Asahara T; Yoshizato K
J Endocrinol; 2007 Sep; 194(3):529-37. PubMed ID: 17761892
[TBL] [Abstract][Full Text] [Related]
18. Factor IX: Insights from knock-out and genetically engineered mice.
Monahan PE
Thromb Haemost; 2008 Oct; 100(4):563-75. PubMed ID: 18841277
[TBL] [Abstract][Full Text] [Related]
19. Critical role of natural killer cells in the rejection of human hepatocytes after xenotransplantation into immunodeficient mice.
Kawahara T; Douglas DN; Lewis J; Lund G; Addison W; Tyrrell DL; Churchill TA; Kneteman NM
Transpl Int; 2010 Sep; 23(9):934-43. PubMed ID: 20180929
[TBL] [Abstract][Full Text] [Related]
20. The uPA(+/+)-SCID mouse with humanized liver as a model for in vivo metabolism of 4-androstene-3,17-dione.
Lootens L; Van Eenoo P; Meuleman P; Leroux-Roels G; Delbeke FT
Drug Metab Dispos; 2009 Dec; 37(12):2367-74. PubMed ID: 19741039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
